<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52420/umj.24.6.103</article-id><article-id custom-type="edn" pub-id-type="custom">FEROTO</article-id><article-id custom-type="elpub" pub-id-type="custom">urmj-2035</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Литературные обзоры | Literature reviews</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Literature reviews</subject></subj-group></article-categories><title-group><article-title>Роль генного полиморфизма коморбидной патологии в формировании осложнений при травмах костей нижних конечностей</article-title><trans-title-group xml:lang="en"><trans-title>The Role of Gene Polymorphism of Comorbid Pathology in the Formation of Complications in Lower Limb Bone Injury</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7634-1280</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савгачев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Savgachev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Виталий Владимирович Савгачев – кандидат медицинских наук, доцент кафедры травматологии и ортопедии</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Vitaly V. Savgachev – Candidate of Sciences (Medicine), Associate Professor of the Department of Traumatology and Orthopedics</p><p>Yaroslavl</p></bio><email xlink:type="simple">hirurg2288@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4562-7731</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шубин</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Shubin</surname><given-names>L. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Леонид Борисович Шубин – кандидат медицинских наук, доцент кафедры общественного здоровья и здравоохранения</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Leonid B. Shubin – Candidate of Sciences (Medicine), Associate Professor of the Department of Public Health and Healthcare</p><p>Yaroslavl</p></bio><email xlink:type="simple">LBSH@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ярославский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2025</year></pub-date><volume>24</volume><issue>6</issue><elocation-id>103–119</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Савгачев В.В., Шубин Л.Б., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Савгачев В.В., Шубин Л.Б.</copyright-holder><copyright-holder xml:lang="en">Savgachev V.V., Shubin L.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/2035">https://www.umjusmu.ru/jour/article/view/2035</self-uri><abstract><p>Причины и виды осложнений в травматологии и ортопедии после консервативного и хирургического лечения при наличии коморбидной патологии всегда привлекают к себе внимание специалистов. Таким образом, поставлена цель – проанализировать и систематизировать данные современной литературы о влиянии полиморфизма генов и сопутствующей патологии на развитие осложнений при лечении травм костей нижних конечностей. В ходе обзора определено, что осложнения в травматологии обусловлены как методами лечения, так и наличием у пациентов коморбидных состояний. Установлено, что полиморфизм определенных генов может оказывать влияние на процесс заживления переломов и общее течение посттравматического периода. В работе выделены гены, ассоциированные с нарушениями соединительной ткани, в т. ч. Коллагенопатиями и ревматическими заболеваниями, такие как HLA-DR4, HLA-DRB1, COL1A1 и COL1A2. Также рассмотрены генетические маркеры, связанные с риском развития сахарного диабета 1-го типа (SOD2, GAD1), артериальной гипертензии (GRK, PLCG2), нарушений метаболизма витамина D (VDR, GC, CYP27B1) и тромбоэмболических осложнений (FGB). Несмотря на выявление множества генов, потенциально влияющих на возникновение осложнений, мы пришли к выводу, что в настоящее время убедительные доказательства существования закономерной генетической предрасположенности отсутствуют, что требует дальнейших глубоких исследований в этом направлении.</p></abstract><trans-abstract xml:lang="en"><p>The causes and types of complications in traumatology and orthopedics following conservative and surgical treatment in patients with comorbid pathology consistently attract the attention of specialists in this field. Therefore, the objective was set – to analyze and systematize data from contemporary literature on the influence of gene polymorphism and comorbid pathology on the development of complications during the treatment of lower limb bone injuries. During the review, it was determined that complications in traumatology are determined by both treatment methods and the presence of comorbid conditions in patients. It has been established that the polymorphism of certain genes can have a significant impact on the fracture healing process and the overall course of the post-traumatic period. The study identifies genes associated with connective tissue disorders, including collagenopathies and rheumatic diseases, such as HLA-DR4, HLA-DRB1, COL1A1, and COL1A2. Also discussed are genetic markers linked to the risk of developing type 1 diabetes mellitus (SOD2, GAD1), arterial hypertension (GRK, PLCG2), disorders of vitamin D metabolism (VDR, GC, CYP27B1), and thromboembolic complications (FGB). Despite identifying numerous genes that could potentially influence the occurrence of complications, we concluded that to date, there is no convincing evidence of a consistent genetic predisposition, which necessitates further in-depth research in this area.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>травма костей нижних конечностей</kwd><kwd>осложнения</kwd><kwd>гены</kwd><kwd>полиморфизм</kwd><kwd>коморбидная патология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lower limb bone injury</kwd><kwd>complications</kwd><kwd>genes</kwd><kwd>polymorphism</kwd><kwd>comorbid pathology</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fomin KN, Belenky IG, Sergeev GD, Majorov BA. Treatment strategy for patients with bone trauma and deep vein thrombosis of lower extremities (literature review). Modern Problems of Science and Education. 2022;(5):130. (In Russ.). DOI: https://doi.org/10.17513/spno.31976.</mixed-citation><mixed-citation xml:lang="en">Fomin KN, Belenky IG, Sergeev GD, Majorov BA. Treatment strategy for patients with bone trauma and deep vein thrombosis of lower extremities (literature review). Modern Problems of Science and Education. 2022;(5):130. (In Russ.). DOI: https://doi.org/10.17513/spno.31976.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Savgachev VV. The significance of the PPARG gene in the recurrence of purulent complications after lower limb bone injury treatment. Patient-Oriented Medicine and Pharmacy. 2025;3(2):36–41. (In Russ.). DOI: https://doi.org/10.37489/2949-1924-0088.</mixed-citation><mixed-citation xml:lang="en">Savgachev VV. The significance of the PPARG gene in the recurrence of purulent complications after lower limb bone injury treatment. Patient-Oriented Medicine and Pharmacy. 2025;3(2):36–41. (In Russ.). DOI: https://doi.org/10.37489/2949-1924-0088.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kishenya MS, Sobolev DV, Anchikova EV, Visyagin AV. Genetic predictors of the risk of developing complications in the immediate postoperative period following combat trauma. Molecular Medicine. 2024; 22(2):48–53. (In Russ.) DOI: https://doi.org/10.29296/24999490-2024-02-08.</mixed-citation><mixed-citation xml:lang="en">Kishenya MS, Sobolev DV, Anchikova EV, Visyagin AV. Genetic predictors of the risk of developing complications in the immediate postoperative period following combat trauma. Molecular Medicine. 2024; 22(2):48–53. (In Russ.) DOI: https://doi.org/10.29296/24999490-2024-02-08.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">De la Vega RE, Atasoy-Zeybek A, Panos JA, van Griensven M, Evans CH, Balmayor ER. Gene therapy for bone healing: Lessons learned and new approaches. Translational Research. 2021;236:1–16. DOI: https://doi.org/10.1016/j.trsl.2021.04.009.</mixed-citation><mixed-citation xml:lang="en">De la Vega RE, Atasoy-Zeybek A, Panos JA, van Griensven M, Evans CH, Balmayor ER. Gene therapy for bone healing: Lessons learned and new approaches. Translational Research. 2021;236:1–16. DOI: https://doi.org/10.1016/j.trsl.2021.04.009.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kahlke V, Schafmayer C, Schniewind B, Seegert D, Schreiber S, Schröder J. Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism? Surgery. 2014;135(4):365–373. DOI: https://doi.org/10.1016/j.surg.2003.08.012.</mixed-citation><mixed-citation xml:lang="en">Kahlke V, Schafmayer C, Schniewind B, Seegert D, Schreiber S, Schröder J. Are postoperative complications genetically determined by TNF-beta NcoI gene polymorphism? Surgery. 2014;135(4):365–373. DOI: https://doi.org/10.1016/j.surg.2003.08.012.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Chen W, Zhao L, Li Y, Liu Z, Gao H, et al. Obesity regulates miR‑467/HoxA10 axis on osteogenic differentiation and fracture healing by BMSC-derived exosome LncRNA H19. Journal of Cellular and Molecular Medicine. 2021;25(3):1712–1724. DOI: https://doi.org/10.1111/jcmm.16273.</mixed-citation><mixed-citation xml:lang="en">Wang Y, Chen W, Zhao L, Li Y, Liu Z, Gao H, et al. Obesity regulates miR‑467/HoxA10 axis on osteogenic differentiation and fracture healing by BMSC-derived exosome LncRNA H19. Journal of Cellular and Molecular Medicine. 2021;25(3):1712–1724. DOI: https://doi.org/10.1111/jcmm.16273.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ranjbarnejad F, Khazaei M, Shahryari A, Khazaei F, Rezakhani L. Recent advances in gene therapy for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(12):1121–1137. DOI: https://doi.org/10.1002/term.3363.</mixed-citation><mixed-citation xml:lang="en">Ranjbarnejad F, Khazaei M, Shahryari A, Khazaei F, Rezakhani L. Recent advances in gene therapy for bone tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(12):1121–1137. DOI: https://doi.org/10.1002/term.3363.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kuchina SN, Spivak IM, Shchegolev AV, Levshankov AI. The role of genetic and epigenetic factors on the development of cognitive deficits in patients with severe trauma after repeated anesthesia (literature review). Messenger of Anesthesiology and Resuscitation. 2024;21(4):124–131. (In Russ.). DOI: https://doi.org/10.24884/2078-5658-2024-21-4-124-131.</mixed-citation><mixed-citation xml:lang="en">Kuchina SN, Spivak IM, Shchegolev AV, Levshankov AI. The role of genetic and epigenetic factors on the development of cognitive deficits in patients with severe trauma after repeated anesthesia (literature review). Messenger of Anesthesiology and Resuscitation. 2024;21(4):124–131. (In Russ.). DOI: https://doi.org/10.24884/2078-5658-2024-21-4-124-131.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Borshchevskaya VN, Kopylov A, Kolomoets IA, Sasko SS, Bachurin SS, Berezovsky DP. Morphological characteristics of the vascular-capillary bed of soft tissues in the fracture region of long tubular bones depending on the carriage of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene. Medical News of the North Caucasus. 2023;18(3):299–303. (In Russ.). DOI: https://doi.org/10.14300/mnnc.2023.18070.</mixed-citation><mixed-citation xml:lang="en">Borshchevskaya VN, Kopylov A, Kolomoets IA, Sasko SS, Bachurin SS, Berezovsky DP. Morphological characteristics of the vascular-capillary bed of soft tissues in the fracture region of long tubular bones depending on the carriage of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene. Medical News of the North Caucasus. 2023;18(3):299–303. (In Russ.). DOI: https://doi.org/10.14300/mnnc.2023.18070.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Leonov DV, Ustinov EM, Derevyannaya VO, Kislitsky VM, Samsonova SK, Alatortseva ME, et al. Genetic polymorphism: Significance and research methods. Amur Medical Journal. 2017;(2):62–67. (In Russ.). EDN: https://elibrary.ru/ZDWNFB.</mixed-citation><mixed-citation xml:lang="en">Leonov DV, Ustinov EM, Derevyannaya VO, Kislitsky VM, Samsonova SK, Alatortseva ME, et al. Genetic polymorphism: Significance and research methods. Amur Medical Journal. 2017;(2):62–67. (In Russ.). EDN: https://elibrary.ru/ZDWNFB.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Theis V, Theiss C. VEGF — a stimulus for neuronal development and regeneration in the CNS and PNS. Current Protein &amp; Peptide Science. 2018;19(6):589–597. DOI: https://doi.org/10.2174/1389203719666180104113937.</mixed-citation><mixed-citation xml:lang="en">Theis V, Theiss C. VEGF — a stimulus for neuronal development and regeneration in the CNS and PNS. Current Protein &amp; Peptide Science. 2018;19(6):589–597. DOI: https://doi.org/10.2174/1389203719666180104113937.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Peters MJ. Association of gene polymorphisms with fracture healing in lower limb injuries. Bone Reports. 2022;16(Suppl):101359. DOI: https://doi.org/10.1016/j.bonr.2022.101359.</mixed-citation><mixed-citation xml:lang="en">Peters MJ. Association of gene polymorphisms with fracture healing in lower limb injuries. Bone Reports. 2022;16(Suppl):101359. DOI: https://doi.org/10.1016/j.bonr.2022.101359.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Guo FQ, Deng M. Correlation between steroid-induced osteonecrosis of the femoral head and hepatic CYP3A activity: A systematic review and meta-analysis. Journal of Investigative Surgery. 2019;32(2):118–126. DOI: https://doi.org/10.1080/08941939.2017.1385663.</mixed-citation><mixed-citation xml:lang="en">Guo FQ, Deng M. Correlation between steroid-induced osteonecrosis of the femoral head and hepatic CYP3A activity: A systematic review and meta-analysis. Journal of Investigative Surgery. 2019;32(2):118–126. DOI: https://doi.org/10.1080/08941939.2017.1385663.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Samad-Zadeh RRO. An analysis of osteosynthesis complications of long bone diaphyseal fractures in patients with polytraumas. University proceedings. Volga region. Medical sciences. 2022;(2):64–73. DOI: https://doi.org/10.21685/2072-3032-2022-2-7.</mixed-citation><mixed-citation xml:lang="en">Samad-Zadeh RRO. An analysis of osteosynthesis complications of long bone diaphyseal fractures in patients with polytraumas. University proceedings. Volga region. Medical sciences. 2022;(2):64–73. DOI: https://doi.org/10.21685/2072-3032-2022-2-7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zamyatin MN, Stoyko YM, Vorobev AV. Prevention of venous thrombosis in inpatient patients. Consilium Medicum. 2006;8(11):95–100. (In Russ.). EDN: https://elibrary.ru/WLGICP.</mixed-citation><mixed-citation xml:lang="en">Zamyatin MN, Stoyko YM, Vorobev AV. Prevention of venous thrombosis in inpatient patients. Consilium Medicum. 2006;8(11):95–100. (In Russ.). EDN: https://elibrary.ru/WLGICP.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Selvaraj V, Sekaran S, Dhanasekaran A, Warrier S. Type 1 collagen: Synthesis, structure and key functions in bone mineralization. Differentiation. 2024;136:100757. DOI: https://doi.org/10.1016/j.diff.2024.100757.</mixed-citation><mixed-citation xml:lang="en">Selvaraj V, Sekaran S, Dhanasekaran A, Warrier S. Type 1 collagen: Synthesis, structure and key functions in bone mineralization. Differentiation. 2024;136:100757. DOI: https://doi.org/10.1016/j.diff.2024.100757.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hendrickx JO, van Gastel J, Leysen H, Santos-Otte P, Premont RT, Martin B, et al. GRK5 — a functional bridge between cardiovascular and neurodegenerative disorders. Frontiers in Pharmacology. 2018;9:1484. DOI: https://doi.org/10.3389/fphar.2018.01484.</mixed-citation><mixed-citation xml:lang="en">Hendrickx JO, van Gastel J, Leysen H, Santos-Otte P, Premont RT, Martin B, et al. GRK5 — a functional bridge between cardiovascular and neurodegenerative disorders. Frontiers in Pharmacology. 2018;9:1484. DOI: https://doi.org/10.3389/fphar.2018.01484.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bizzari S, Nair P, Al Ali MT, Hamzeh AR. Meta-analyses of the association of HLA-DRB1 alleles with rheumatoid arthritis among Arabs. International Journal of Rheumatic Diseases. 2017;20(7):832–838. DOI: https://doi.org/10.1111/1756–185X.12922.</mixed-citation><mixed-citation xml:lang="en">Bizzari S, Nair P, Al Ali MT, Hamzeh AR. Meta-analyses of the association of HLA-DRB1 alleles with rheumatoid arthritis among Arabs. International Journal of Rheumatic Diseases. 2017;20(7):832–838. DOI: https://doi.org/10.1111/1756–185X.12922.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Miyachi Y, Miyazawa T, Ogawa Y. HNF1A mutations and beta cell dysfunction in diabetes. International Journal of Molecular Sciences. 2022;23(6):3222. DOI: https://doi.org/10.3390/ijms23063222.</mixed-citation><mixed-citation xml:lang="en">Miyachi Y, Miyazawa T, Ogawa Y. HNF1A mutations and beta cell dysfunction in diabetes. International Journal of Molecular Sciences. 2022;23(6):3222. DOI: https://doi.org/10.3390/ijms23063222.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Love-Gregory L, Permutt MA. HNF4A genetic variants: Role in diabetes. Current Opinion in Clinical Nutrition &amp; Metabolic Care. 2007;10(4):397–402. DOI: https://doi.org/10.1097/MCO.0b013e3281e3888d.</mixed-citation><mixed-citation xml:lang="en">Love-Gregory L, Permutt MA. HNF4A genetic variants: Role in diabetes. Current Opinion in Clinical Nutrition &amp; Metabolic Care. 2007;10(4):397–402. DOI: https://doi.org/10.1097/MCO.0b013e3281e3888d.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Samarin MA, Asi Habiballah ZA, Krivova AV, Rodionova SS, Solomynnik IA. Epidemiology of fractures of the proximal femur in people older than 50 years: What has changed in the last 30 years? N. N. Priorov Journal of Traumatology and Orthopedics. 2022;29(2):181–191. (In Russ.). DOI: https://doi.org/10.17816/vto109748.</mixed-citation><mixed-citation xml:lang="en">Samarin MA, Asi Habiballah ZA, Krivova AV, Rodionova SS, Solomynnik IA. Epidemiology of fractures of the proximal femur in people older than 50 years: What has changed in the last 30 years? N. N. Priorov Journal of Traumatology and Orthopedics. 2022;29(2):181–191. (In Russ.). DOI: https://doi.org/10.17816/vto109748.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jia Z, Liu J, Wang J. circRNA-MSR regulates the expression of FBXO21 to inhibit chondrocyte autophagy by targeting miR‑761 in osteoarthritis. The Kaohsiung Journal of Medical Sciences. 2022;38(12):1168–1177. DOI: https://doi.org/10.1002/kjm2.12604.</mixed-citation><mixed-citation xml:lang="en">Jia Z, Liu J, Wang J. circRNA-MSR regulates the expression of FBXO21 to inhibit chondrocyte autophagy by targeting miR‑761 in osteoarthritis. The Kaohsiung Journal of Medical Sciences. 2022;38(12):1168–1177. DOI: https://doi.org/10.1002/kjm2.12604.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Stashkevich DS, Khromova EB, Devald IV, Khodus EA, Filippova YY, Burmistrova AL. Class II TNFA-HLA haplotypes as predictive markers of rheumatoid arthritis. South Ural Medical Journal. 2022;(1):95–104. (In Russ.). EDN: https://elibrary.ru/MQPODC.</mixed-citation><mixed-citation xml:lang="en">Stashkevich DS, Khromova EB, Devald IV, Khodus EA, Filippova YY, Burmistrova AL. Class II TNFA-HLA haplotypes as predictive markers of rheumatoid arthritis. South Ural Medical Journal. 2022;(1):95–104. (In Russ.). EDN: https://elibrary.ru/MQPODC.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka Y. Rheumatoid arthritis. Inflammation and Regeneration. 2020;40:20. DOI: https://doi.org/10.1186/s41232-020-00133-8.</mixed-citation><mixed-citation xml:lang="en">Tanaka Y. Rheumatoid arthritis. Inflammation and Regeneration. 2020;40:20. DOI: https://doi.org/10.1186/s41232-020-00133-8.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Breidert M, Eftekhari P, Louis F, Rotoiu C, Rath T, Neurath MF, et al. Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients. Crohn’s &amp; Colitis 360. 2020;2(2):otaa37. DOI: https://doi.org/10.1093/crocol/otaa037.</mixed-citation><mixed-citation xml:lang="en">Breidert M, Eftekhari P, Louis F, Rotoiu C, Rath T, Neurath MF, et al. Functional molecular network analysis enables prediction of response to vedolizumab therapy in anti-TNF refractory IBD patients. Crohn’s &amp; Colitis 360. 2020;2(2):otaa37. DOI: https://doi.org/10.1093/crocol/otaa037.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Marin Rubio LA, Rada R, Ontañon J. New HLA-DQB1 intronic variants detected by next-generation sequencing. HLA. 2022;99(6):669–670. DOI: https://doi.org/10.1111/tan.14567.</mixed-citation><mixed-citation xml:lang="en">Marin Rubio LA, Rada R, Ontañon J. New HLA-DQB1 intronic variants detected by next-generation sequencing. HLA. 2022;99(6):669–670. DOI: https://doi.org/10.1111/tan.14567.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Chu CS, Chu CL, Liang CK, Lu T, Lin YT, Chou MY, et al. Association between polymorphisms in dopamine-related genes and orthopedic pain expression in a Chinese elderly population. Pain Practice. 2019; 19(2):211–221. DOI: https://doi.org/10.1111/papr.12737.</mixed-citation><mixed-citation xml:lang="en">Chu CS, Chu CL, Liang CK, Lu T, Lin YT, Chou MY, et al. Association between polymorphisms in dopamine-related genes and orthopedic pain expression in a Chinese elderly population. Pain Practice. 2019; 19(2):211–221. DOI: https://doi.org/10.1111/papr.12737.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Miromanov AM, Gusev KA, Staroselnikov AN, Mironova OB. Modern genetic and immunological aspects of fracture consolidation disorders pathogenesis (literature review). Acta Biomedica Scientifica. 2022; 7(2):49–64. (In Russ.). DOI: https://doi.org/10.29413/ABS.2022-7.2.6.</mixed-citation><mixed-citation xml:lang="en">Miromanov AM, Gusev KA, Staroselnikov AN, Mironova OB. Modern genetic and immunological aspects of fracture consolidation disorders pathogenesis (literature review). Acta Biomedica Scientifica. 2022; 7(2):49–64. (In Russ.). DOI: https://doi.org/10.29413/ABS.2022-7.2.6.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Poryadin GV, Eremin DA, Khelminskaya NM, Kravets VI, Zhitareva IV, Posadskaya AV, et al. Efficacy of the jawbone defect elimination. Bulletin of RSMU. 2023;(6):97–101. DOI: https://doi.org/10.24075/vrgmu.2023.044.</mixed-citation><mixed-citation xml:lang="en">Poryadin GV, Eremin DA, Khelminskaya NM, Kravets VI, Zhitareva IV, Posadskaya AV, et al. Efficacy of the jawbone defect elimination. Bulletin of RSMU. 2023;(6):97–101. DOI: https://doi.org/10.24075/vrgmu.2023.044.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Dong W, Jia C, Li J, Zhou Y, Luo Y, Liu J, et al. Fisetin attenuates diabetic nephropathy-induced podocyte injury by inhibiting NLRP3 inflammasome. Frontiers in Pharmacology. 2022;13:783706. DOI: https://doi.org/10.3389/fphar.2022.783706.</mixed-citation><mixed-citation xml:lang="en">Dong W, Jia C, Li J, Zhou Y, Luo Y, Liu J, et al. Fisetin attenuates diabetic nephropathy-induced podocyte injury by inhibiting NLRP3 inflammasome. Frontiers in Pharmacology. 2022;13:783706. DOI: https://doi.org/10.3389/fphar.2022.783706.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Borysewicz-Sańczyk H, Sawicka B, Wawrusiewicz-Kurylonek N, Głowińska-Olszewska B, Kadłubiska A, Gościk J, et al. Genetic association study of IL2RA, IFIH1, and CTLA‑4 polymorphisms with autoimmune thyroid diseases and type 1 diabetes. Frontiers in Pediatrics. 2020;8:481. DOI: https://doi.org/10.3389/fped.2020.00481.</mixed-citation><mixed-citation xml:lang="en">Borysewicz-Sańczyk H, Sawicka B, Wawrusiewicz-Kurylonek N, Głowińska-Olszewska B, Kadłubiska A, Gościk J, et al. Genetic association study of IL2RA, IFIH1, and CTLA‑4 polymorphisms with autoimmune thyroid diseases and type 1 diabetes. Frontiers in Pediatrics. 2020;8:481. DOI: https://doi.org/10.3389/fped.2020.00481.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Khomynets VV, Shchukin AV, Mykhailov SV, Shakun DA, Endovitskay MV, Zacharov MV. Treatment of the low extremity severe mechanical injury with uncompensated ischemia (case report). Traumatology and Orthopedics of Russia. 2020;26(1):153–163. (In Russ.). DOI: https://doi.org/10.21823/2311-2905-2020-26-1-153-163.</mixed-citation><mixed-citation xml:lang="en">Khomynets VV, Shchukin AV, Mykhailov SV, Shakun DA, Endovitskay MV, Zacharov MV. Treatment of the low extremity severe mechanical injury with uncompensated ischemia (case report). Traumatology and Orthopedics of Russia. 2020;26(1):153–163. (In Russ.). DOI: https://doi.org/10.21823/2311-2905-2020-26-1-153-163.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson GC, Payne F, Nutland S, Stevens H, Tuomilehto-Wolf E, Tuomilehto J, et al. A comprehensive, statistically powered analysis of GAD2 in type 1 diabetes. Diabetes. 2002;51(9):2866–2870. DOI: https://doi.org/10.2337/diabetes.51.9.2866.</mixed-citation><mixed-citation xml:lang="en">Johnson GC, Payne F, Nutland S, Stevens H, Tuomilehto-Wolf E, Tuomilehto J, et al. A comprehensive, statistically powered analysis of GAD2 in type 1 diabetes. Diabetes. 2002;51(9):2866–2870. DOI: https://doi.org/10.2337/diabetes.51.9.2866.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zurawek M, Dzikiewicz-Krawczyk A, Izykowska K, Ziolkowska-Suchanek I, Skowronska B, Czainska M, et al. miR‑487a‑3p upregulated in type 1 diabetes targets CTLA4 and FOXO3. Diabetes Research and Clinical Practice. 2018;142:146–153. DOI: https://doi.org/10.1016/j.diabres.2018.05.044.</mixed-citation><mixed-citation xml:lang="en">Zurawek M, Dzikiewicz-Krawczyk A, Izykowska K, Ziolkowska-Suchanek I, Skowronska B, Czainska M, et al. miR‑487a‑3p upregulated in type 1 diabetes targets CTLA4 and FOXO3. Diabetes Research and Clinical Practice. 2018;142:146–153. DOI: https://doi.org/10.1016/j.diabres.2018.05.044.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai AP, Dong C, Lin PB, Messenger EJ, Casali BT, Moutinho M, et al. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease. Genome Medicine. 2022; 14(1):17. DOI: https://doi.org/10.1186/s13073-022-01022-0.</mixed-citation><mixed-citation xml:lang="en">Tsai AP, Dong C, Lin PB, Messenger EJ, Casali BT, Moutinho M, et al. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease. Genome Medicine. 2022; 14(1):17. DOI: https://doi.org/10.1186/s13073-022-01022-0.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Zelenskaya EM, Lifshits GI. Genetic markers of vitamin D metabolism and approaches to hypovitaminosis correction in adults. Siberian Medical Review. 2018;(6):5–11. (In Russ.). DOI: https://doi.org/10.20333/2500136-2018-6-5-11.</mixed-citation><mixed-citation xml:lang="en">Zelenskaya EM, Lifshits GI. Genetic markers of vitamin D metabolism and approaches to hypovitaminosis correction in adults. Siberian Medical Review. 2018;(6):5–11. (In Russ.). DOI: https://doi.org/10.20333/2500136-2018-6-5-11.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Yang R, Chen J, Zhang J, Qin R, Wang R, Qiu Y, et al. 1,25‑Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2‑p16 signal axis. Aging Cell. 2020;19(2): e13095. DOI: https://doi.org/10.1111/acel.13095.</mixed-citation><mixed-citation xml:lang="en">Yang R, Chen J, Zhang J, Qin R, Wang R, Qiu Y, et al. 1,25‑Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2‑p16 signal axis. Aging Cell. 2020;19(2): e13095. DOI: https://doi.org/10.1111/acel.13095.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Volkov E, Goloshchapov A, Mustafin R, Nostaeva S. Factor analysis of clinical and biochemical parameters of bone remodeling changes associated with leading VDR polymorphisms in patients with aseptic necrosis of the femoral head. Genij Ortopedii. 2023;29(1):57–63. (In Russ., Eng.). DOI: https://doi.org/10.18019/1028-4427-2023-29-1-57-63.</mixed-citation><mixed-citation xml:lang="en">Volkov E, Goloshchapov A, Mustafin R, Nostaeva S. Factor analysis of clinical and biochemical parameters of bone remodeling changes associated with leading VDR polymorphisms in patients with aseptic necrosis of the femoral head. Genij Ortopedii. 2023;29(1):57–63. (In Russ., Eng.). DOI: https://doi.org/10.18019/1028-4427-2023-29-1-57-63.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Cui J, Shibata Y, Zhu T, Zhou J, Zhang J. Osteocytes in bone aging: Advances, challenges, and future perspectives. Ageing Research Reviews. 2022;77:101608. DOI: https://doi.org/10.1016/j.arr.2022.101608.</mixed-citation><mixed-citation xml:lang="en">Cui J, Shibata Y, Zhu T, Zhou J, Zhang J. Osteocytes in bone aging: Advances, challenges, and future perspectives. Ageing Research Reviews. 2022;77:101608. DOI: https://doi.org/10.1016/j.arr.2022.101608.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Trajanoska K, Morris JA, Oei L, Zheng HF, Evans DM, Kiel DP, et al.; GEFOS/GENOMOS consortium and the 23andMe research team. Assessment of the genetic and clinical determinants of fracture risk: Genome wide association and mendelian randomisation study. BMJ. 2018;362:k3225. DOI: https://doi.org/10.1136/bmj.k3225.</mixed-citation><mixed-citation xml:lang="en">Trajanoska K, Morris JA, Oei L, Zheng HF, Evans DM, Kiel DP, et al.; GEFOS/GENOMOS consortium and the 23andMe research team. Assessment of the genetic and clinical determinants of fracture risk: Genome wide association and mendelian randomisation study. BMJ. 2018;362:k3225. DOI: https://doi.org/10.1136/bmj.k3225.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Komarova LN, Kiseleva MA, Nabieva KU, Brutskaya NV. Acute thrombosis of the femoral-popliteal segment, complicated by PE. Description of the clinical case. Meditsinskaya nauka i obrazovanie Urala. 2021; 22(4):89–93. (In Russ.). DOI: https://doi.org/10.36361/1814-8999-2021-22-4-89-93.</mixed-citation><mixed-citation xml:lang="en">Komarova LN, Kiseleva MA, Nabieva KU, Brutskaya NV. Acute thrombosis of the femoral-popliteal segment, complicated by PE. Description of the clinical case. Meditsinskaya nauka i obrazovanie Urala. 2021; 22(4):89–93. (In Russ.). DOI: https://doi.org/10.36361/1814-8999-2021-22-4-89-93.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Peregud DI, Baronets VYu, Lobacheva AS, Ivanov AS, Garmash IV, Arisheva OS, et al. IL6 rs1800795 SNP may relate to cardiovascular pathology in alcohol abusers. Medical Genetics. 2021;20(4):30–42. (In Russ.). DOI: https://doi.org/10.25557/2073-7998.2021.04.30-42.</mixed-citation><mixed-citation xml:lang="en">Peregud DI, Baronets VYu, Lobacheva AS, Ivanov AS, Garmash IV, Arisheva OS, et al. IL6 rs1800795 SNP may relate to cardiovascular pathology in alcohol abusers. Medical Genetics. 2021;20(4):30–42. (In Russ.). DOI: https://doi.org/10.25557/2073-7998.2021.04.30-42.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Padda J, Khalid K, Mohan A, Pokhriyal S, Batra N, Hitawala G, et al. Factor V Leiden G1691A and prothrombin gene G20210A mutations on pregnancy outcome. Cureus. 2021;13(8):e17185. DOI: https://doi.org/10.7759/cureus.17185.</mixed-citation><mixed-citation xml:lang="en">Padda J, Khalid K, Mohan A, Pokhriyal S, Batra N, Hitawala G, et al. Factor V Leiden G1691A and prothrombin gene G20210A mutations on pregnancy outcome. Cureus. 2021;13(8):e17185. DOI: https://doi.org/10.7759/cureus.17185.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Tkachuk EA, Seminsky IZh. Methods of modern genetics. Baikal Medical Journal. 2023;2(1):60–71. (In Russ.). DOI: https://doi.org/10.57256/2949-0715-2023-1-60-71.</mixed-citation><mixed-citation xml:lang="en">Tkachuk EA, Seminsky IZh. Methods of modern genetics. Baikal Medical Journal. 2023;2(1):60–71. (In Russ.). DOI: https://doi.org/10.57256/2949-0715-2023-1-60-71.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z, Yang Z, Chen M, Li Y. Compound heterozygous protein C deficiency with pulmonary embolism caused by a novel PROC gene mutation: Case report and literature review. Medicine. 2022;101(42):e31221. DOI: https://doi.org/10.1097/MD.0000000000031221.</mixed-citation><mixed-citation xml:lang="en">Zhang Z, Yang Z, Chen M, Li Y. Compound heterozygous protein C deficiency with pulmonary embolism caused by a novel PROC gene mutation: Case report and literature review. Medicine. 2022;101(42):e31221. DOI: https://doi.org/10.1097/MD.0000000000031221.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Papachristou NI, Blair HC, Kypreos KE, Papachristou D. High-density lipoprotein (HDL) metabolism and bone mass. Journal of Endocrinology. 2017;233(2):95–107. DOI: https://doi.org/10.1530/JOE‑16-0657.</mixed-citation><mixed-citation xml:lang="en">Papachristou NI, Blair HC, Kypreos KE, Papachristou D. High-density lipoprotein (HDL) metabolism and bone mass. Journal of Endocrinology. 2017;233(2):95–107. DOI: https://doi.org/10.1530/JOE‑16-0657.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Dmitriev IV, Dorosevich AE. Fat embolism: History and terminological features. Ural Medical Journal. 2017;(4):88–92. (In Russ.). EDN: https://elibrary.ru/YPZZCD.</mixed-citation><mixed-citation xml:lang="en">Dmitriev IV, Dorosevich AE. Fat embolism: History and terminological features. Ural Medical Journal. 2017;(4):88–92. (In Russ.). EDN: https://elibrary.ru/YPZZCD.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gabdullin MM, Pankov IO, Sirazitdinov SD, Emelin AL. Study of interleukin-6 in patients with severe lower limb trauma complicated by fat embolism syndrome. In: Pankov IO (ed.). Traumatology-Orthopedics-Reconstructive Surgery: Collection of articles and abstracts. Kazan; 2024. P. 11–17. (In Russ.). EDN: https://elibrary.ru/DZIPKR.</mixed-citation><mixed-citation xml:lang="en">Gabdullin MM, Pankov IO, Sirazitdinov SD, Emelin AL. Study of interleukin-6 in patients with severe lower limb trauma complicated by fat embolism syndrome. In: Pankov IO (ed.). Traumatology-Orthopedics-Reconstructive Surgery: Collection of articles and abstracts. Kazan; 2024. P. 11–17. (In Russ.). EDN: https://elibrary.ru/DZIPKR.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Tikhilov RM, Fomin NF, Koryshkov NA, Emelyanov VG, Privalov AM. Current aspects of treating consequences of fractures of the hindfoot bones. Traumatology and Orthopedics of Russia. 2009;(2):144–149. (In Russ.). EDN: https://elibrary.ru/KYQZOZ.</mixed-citation><mixed-citation xml:lang="en">Tikhilov RM, Fomin NF, Koryshkov NA, Emelyanov VG, Privalov AM. Current aspects of treating consequences of fractures of the hindfoot bones. Traumatology and Orthopedics of Russia. 2009;(2):144–149. (In Russ.). EDN: https://elibrary.ru/KYQZOZ.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Olkova MV, Petrushenko VS, Ponomarev GY. Analysis of 13 TP53 and WRAP53 polymorphism frequencies in Russian populations. Bulletin of RSMU. 2021;(1):30–39. DOI: https://doi.org/10.24075/brsmu.2021.001.</mixed-citation><mixed-citation xml:lang="en">Olkova MV, Petrushenko VS, Ponomarev GY. Analysis of 13 TP53 and WRAP53 polymorphism frequencies in Russian populations. Bulletin of RSMU. 2021;(1):30–39. DOI: https://doi.org/10.24075/brsmu.2021.001.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Gladkova EN, Kozhemyakina EV, Evstigneeva LP, Tikhonova VA, Kamkina LN, Bannykh OV, et al. Osteoporosis and associated fractures in older patients with inflammatory rheumatic diseases. Osteoporosis and Bone Diseases. 2015;18(2):9–14. (In Russ.) DOI: https://doi.org/10.14341/osteo201529-14.</mixed-citation><mixed-citation xml:lang="en">Gladkova EN, Kozhemyakina EV, Evstigneeva LP, Tikhonova VA, Kamkina LN, Bannykh OV, et al. Osteoporosis and associated fractures in older patients with inflammatory rheumatic diseases. Osteoporosis and Bone Diseases. 2015;18(2):9–14. (In Russ.) DOI: https://doi.org/10.14341/osteo201529-14.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Liu YQ, Chang LW, Yang HW, Li JR, Chen YM, Hung SC, et al. Polygenic risk score as a predictor of bone fracture or osteoporosis in prostate cancer patients receiving androgen deprivation therapy. Cancer Medicine. 2025;14(22):e71395. DOI: https://doi.org/10.1002/cam4.71395.</mixed-citation><mixed-citation xml:lang="en">Liu YQ, Chang LW, Yang HW, Li JR, Chen YM, Hung SC, et al. Polygenic risk score as a predictor of bone fracture or osteoporosis in prostate cancer patients receiving androgen deprivation therapy. Cancer Medicine. 2025;14(22):e71395. DOI: https://doi.org/10.1002/cam4.71395.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Ze Y, Wu Y, Tan Z, Li R, Li R, Gao W, et al. Signaling pathway mechanisms of circadian clock gene Bmal1 regulating bone and cartilage metabolism: A review. Bone Research. 2025;13(1):19. DOI: https://doi.org/10.1038/s41413-025-00403-6.</mixed-citation><mixed-citation xml:lang="en">Ze Y, Wu Y, Tan Z, Li R, Li R, Gao W, et al. Signaling pathway mechanisms of circadian clock gene Bmal1 regulating bone and cartilage metabolism: A review. Bone Research. 2025;13(1):19. DOI: https://doi.org/10.1038/s41413-025-00403-6.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H, Shao Y, Yao Z, Liu L, Zhang H, Yin J, et al. Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7. Annals of the Rheumatic Diseases. 2022;81(5):676–686. DOI: https://doi.org/10.1136/annrheumdis-2021-221513.</mixed-citation><mixed-citation xml:lang="en">Zhang H, Shao Y, Yao Z, Liu L, Zhang H, Yin J, et al. Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7. Annals of the Rheumatic Diseases. 2022;81(5):676–686. DOI: https://doi.org/10.1136/annrheumdis-2021-221513.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Choi SW, Mak TS, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nature Protocols. 2020;15(9):2759–2772. DOI: https://doi.org/10.1038/s41596-020-0353-1.</mixed-citation><mixed-citation xml:lang="en">Choi SW, Mak TS, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nature Protocols. 2020;15(9):2759–2772. DOI: https://doi.org/10.1038/s41596-020-0353-1.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Liu K, Chen B, Zeng F, Wang G, Wu X, Liu Y, et al. ApoE/NOS3 knockout mice as a novel cardiovascular disease model of hypertension and atherosclerosis. Genes. 2022;13(11):1998. DOI: https://doi.org/10.3390/genes13111998.</mixed-citation><mixed-citation xml:lang="en">Liu K, Chen B, Zeng F, Wang G, Wu X, Liu Y, et al. ApoE/NOS3 knockout mice as a novel cardiovascular disease model of hypertension and atherosclerosis. Genes. 2022;13(11):1998. DOI: https://doi.org/10.3390/genes13111998.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Forgetta V, Keller-Baruch J, Forest M, Durand A, Bhatnagar S, Kemp JP, et al. Development of a polygenic risk score to improve screening for fracture risk: A genetic risk prediction study. PLoS Medicine. 2020;17(7): e1003152. DOI: https://doi.org/10.1371/journal.pmed.1003152.</mixed-citation><mixed-citation xml:lang="en">Forgetta V, Keller-Baruch J, Forest M, Durand A, Bhatnagar S, Kemp JP, et al. Development of a polygenic risk score to improve screening for fracture risk: A genetic risk prediction study. PLoS Medicine. 2020;17(7): e1003152. DOI: https://doi.org/10.1371/journal.pmed.1003152.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Lu T, Forgetta V, Keller-Baruch J, Nethander M, Bennett D, Forest M, et al. Improved prediction of fracture risk leveraging a genome-wide polygenic risk score. Genome Medicine. 2021;13(1):16. DOI: https://doi.org/10.1186/s13073-021-00838-6.</mixed-citation><mixed-citation xml:lang="en">Lu T, Forgetta V, Keller-Baruch J, Nethander M, Bennett D, Forest M, et al. Improved prediction of fracture risk leveraging a genome-wide polygenic risk score. Genome Medicine. 2021;13(1):16. DOI: https://doi.org/10.1186/s13073-021-00838-6.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Tao J, Miao R, Liu G, Qiu X, Yang B, Tan X, et al. Spatiotemporal correlation between HIF-1α and bone regeneration. The FASEB Journal. 2022;36(10):e22520. DOI: https://doi.org/10.1096/fj.202200329RR.</mixed-citation><mixed-citation xml:lang="en">Tao J, Miao R, Liu G, Qiu X, Yang B, Tan X, et al. Spatiotemporal correlation between HIF-1α and bone regeneration. The FASEB Journal. 2022;36(10):e22520. DOI: https://doi.org/10.1096/fj.202200329RR.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Jiao G, Ren S, Zhang X, Li C, Wu W, et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis. Stem Cell Research &amp; Therapy. 2020;11(1):38. DOI: https://doi.org/10.1186/s13287-020-1562-9.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Jiao G, Ren S, Zhang X, Li C, Wu W, et al. Exosomes from bone marrow mesenchymal stem cells enhance fracture healing through the promotion of osteogenesis and angiogenesis. Stem Cell Research &amp; Therapy. 2020;11(1):38. DOI: https://doi.org/10.1186/s13287-020-1562-9.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Camal Ruggieri IN, Cícero AM, Issa JPM, Feldman S. Bone fracture healing: Perspectives according to molecular basis. Journal of Bone and Mineral Metabolism. 2021;39(3):311–331. DOI: https://doi.org/10.1007/s00774-020-01168-0.</mixed-citation><mixed-citation xml:lang="en">Camal Ruggieri IN, Cícero AM, Issa JPM, Feldman S. Bone fracture healing: Perspectives according to molecular basis. Journal of Bone and Mineral Metabolism. 2021;39(3):311–331. DOI: https://doi.org/10.1007/s00774-020-01168-0.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Mary L, Leclerc D, Gilot D, Belaud-Rotureau MA, Jaillard S. The TALE never ends: A comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects. Human Mutation. 2022;43(9):1125–1148. DOI: https://doi.org/10.1002/humu.24388.</mixed-citation><mixed-citation xml:lang="en">Mary L, Leclerc D, Gilot D, Belaud-Rotureau MA, Jaillard S. The TALE never ends: A comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects. Human Mutation. 2022;43(9):1125–1148. DOI: https://doi.org/10.1002/humu.24388.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Proietto J. Obesity and bone. F1000Research. 2020;9:F1000 Faculty Rev-1111. DOI: https://doi.org/10.12688/f1000research.20875.1.</mixed-citation><mixed-citation xml:lang="en">Proietto J. Obesity and bone. F1000Research. 2020;9:F1000 Faculty Rev-1111. DOI: https://doi.org/10.12688/f1000research.20875.1.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
